Treating bacterial vaginosis: A meta-analysis which included 24 controlled clinical trials 4,422 participants; AMSTAR score 8/11 which compared several treatments against placebo and between themselves in terms of clinical failure found that topical metronidazole was more effectiveness when compared to placebo RR 0.59:0.44–0.79 95% CI, and Vaginal clindamycin was more effectiveness when compared to placebo RR 0.19: 0.09–0.4195% CI.
Tratamiento de la vaginosis bacteriana. Un metaanálisis que incluyó 24 ensayos clínicos controlados con un total de 4422 participantes, con un puntaje AMSTAR 8/11 comparó varios tratamientos contra placebo y entre sí para falla clínica. El metronidazol tópico fue superior al placebo RR = 0,59; IC 95%: 0,44-0,79. La clindamicina vaginal fue superior al placebo RR = 0,19; IC 95%: 0,09-0,41.